Less than one year ago, Rep. John P. "Jack" Murtha, D-Pa., came crashing onto the national scene with his opinion that the U.S. military could accomplish nothing more in Iraq and should be pulled out of the war zone. It was a harsh opinion -- and one his Democratic partners thought might hurt their party at a time when they were trying to gain control of Congress. The fact that the Democrats had been seen as weak on national security didn't help. And then a funny thing happened.

Murtha, 74 -- a decorated Marine and the first combat veteran of the Vietnam War elected to the House of Representatives -- became one of the most popular Democrats around, despite or maybe because of his passionate beliefs. Once a behind-the-scenes kind of man, he is now in the public eye. He's out raising money for Democrats in many states. He's attending fundraising events with Al Gore and others. And he's gathering allies at every turn. And while he still faces opposition, he believes that he must make public what he stands for. And so he does. And because of his recent uncharacteristic charismatic presence, details about this once-to-himself man are emerging. Details like these: A local airport is named for him. An institute for the study of neuroscience and pain is named for him. And a breast cancer center bears the name of his wife, Joyce.

The Joyce Murtha Breast Care Center at Windber Medical Center opened its doors in February 2002. Located in Windber, Pennsylvania, this center began as a collaboration between Walter Reed Army Medical Center and Windber Medical Center and ever since its beginning has offered full diagnostic services for breast health and disease in one convenient location.

Murtha is surely raising awareness with his opinion about the military and national security and war. And even breast cancer gets a little press out of the whole frenzy surrounding this man and his efforts. Which reminds me that somehow, breast cancer seems to touch the lives of just about everyone is some way.

The beauty of blogs and small newspapers. If you want to read interesting reporting, take the road less traveled where writers are allowed to follow the compass to places large corporate media does not seem to venture.

In Daily News Central's FDA's Ok of Cervical Cancer Vaccine May Spawn Multibillion Dollar Market is an excellent piece explaining all the major participants and motives behind the recently approved cervical cancer vaccine. While no one expects that altruism is ever at play when it comes to business, understanding the reasoning behind the actions at least gives all the rest of us a chance to understand the brouhaha this particular cancer vaccine has, and will continue, to create.

While GlaxoSmithKline has a cervical cancer vaccine they hope will be approved and available next year, Merck is first out of the gate with the FDA approval of Gardasil. The company needs this to be a success after taking a financial hit a few years ago over its drug Vioxx, a pain pill that was widely-prescribed and later withdrawn from the market over safety concerns.

In the last year, Merck has quietly spent an estimated $1 million dollars launching the Tell Someone campaign and was connected to the Make the Connection campaign, both designed to raise a general public awareness and hopefully to ease the concerns of the evangelical Christian opposition they anticipated over a cancer vaccine so closely linked to sexual activity and teenage girls. The cancer vaccine works for girls who are virgins, who are not yet sexually active. You can see the potential for religious opposition considering their only stand on prevention in general when it comes to sex is to instruct teens not to have sex.

On June 29, immunization experts at the CDC will hold a meeting to decide if the new cervical cancer vaccine should be added to a list of mandatory vaccines administered to the youth in this country. Congress will have a vote on adding the cancer vaccine to immunization programs, and the health officials in each state will decide if the new vaccine will be required. The battle over a sexually-transmitted cancer and cancer prevention for virgins has just begun.

It is official. The first cervical cancer vaccine has been approved by the Food and Drug Administration, FDA. Merck's Gardasil cervical cancer vaccine is the first of several cancer vaccines expected to win approval this year. Gardasil, which targets human papillomavirus, HPV, will be given in three doses over six months. HPV is known to be responsible for the majority of cervical cancer cases.

The cervical cancer vaccine is not without its warnings though. In an earlier post, cervical cancer vaccine protects and promotes cancer, we noted a caution that research has shown the vaccine can actually raise the risk of cervical cancer if the woman is already infected with HPV at the time she receives the cervical cancer vaccine. So, it is not for every woman.

We also noted in an earlier post, cancer vaccine facing Christian Right opposition, there is strong objection to the cervical cancer vaccine based on religious convictions regarding sex and teenage girls. According to experts, girls in their early teens are the most likely to benefit from the cervical cancer vaccine.